Literature DB >> 971720

Relationship between the enhanced expression of histocompatibility antigens on interferon-treated L 1210 cells and their position in the cell cycle.

D Killander, P Lindahl, L Lundin, P Leary, I Gresser.   

Abstract

We have determined the cell cycle position of individual mouse leukemia L 1210 cells by cytophotometric and autoradiographic techniques and simultaneously determined the amount of histocompatibility antigens expressed on the surface of individual cells by quantitative immunofluorescence. Interferon treatment of L 1210 cells was accompanied by an enhanced expression of histocompatibility surface antigens. The distribution of interferon-treated cells in the various phases of the cell cycle was similar to that for control cells and the enhanced expression of histocompatibility antigens was observed on interferon-treated cells in all phases of the cell cycle. We conclude, therefore, that this enhancement is not due to a preferential concentration of these cells in any one particular phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 971720     DOI: 10.1002/eji.1830060112

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Modulation of immune responses in newborn and adult mice by interferon.

Authors:  O Strannegård; I Larsson; E Lundgren; H Miörner; H Persson
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

Review 2.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 3.  IFN-induced modulation of histocompatibility antigens on human cells. Background, mechanisms and perspectives.

Authors:  M Hokland; P Basse; J Justesen; P Hokland
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

4.  Interferon treatment inhibits pinocytosis.

Authors:  D K Wilcox; P A Whitaker-Dowling; J S Youngner; C C Widnell
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

5.  Utility of interferons in clinical radiotherapy.

Authors:  K L Mossman; L T Hill; A Dritschilo
Journal:  J Natl Med Assoc       Date:  1982-11       Impact factor: 1.798

6.  Interferon increases HLA synthesis in melanoma cells: interferon-resistant and -sensitive cell lines.

Authors:  T Y Basham; M F Bourgeade; A A Creasey; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

Review 7.  Advances in interferon research - Medical Staff Conference.

Authors:  A A Creasey; T C Merigan
Journal:  West J Med       Date:  1982-03

8.  Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.

Authors:  K Höbarth; A Hallas; G Steiner; A Gomahr; W Aulitzky; M Marberger
Journal:  Urol Res       Date:  1996

9.  Effects of interferon and PKC modulators on human glioma protein kinase C, cell proliferation, and cell cycle.

Authors:  M Acevedo-Duncan; R Zhang; D R Cooper; H M Greenberg
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

Review 10.  The antitumor effects of interferon.

Authors:  I Gresser
Journal:  Med Oncol Tumor Pharmacother       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.